| __timestamp | Exelixis, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 25111000 | 1777824000000 |
| Thursday, January 1, 2015 | 37172000 | 1807378000000 |
| Friday, January 1, 2016 | 191454000 | 1732051000000 |
| Sunday, January 1, 2017 | 452477000 | 1770531000000 |
| Monday, January 1, 2018 | 853826000 | 2097224000000 |
| Tuesday, January 1, 2019 | 967775000 | 3291188000000 |
| Wednesday, January 1, 2020 | 987538000 | 3197812000000 |
| Friday, January 1, 2021 | 1434970000 | 3569006000000 |
| Saturday, January 1, 2022 | 1611062000 | 4027478000000 |
| Sunday, January 1, 2023 | 1830208000 | 4263762000000 |
| Monday, January 1, 2024 | 2168701000 | 4263762000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, Takeda Pharmaceutical Company Limited and Exelixis, Inc. have showcased distinct revenue trajectories from 2014 to 2023. Takeda, a global leader, has consistently demonstrated robust growth, with revenues surging by approximately 140% over the decade, peaking at over $4 trillion in 2023. This growth underscores Takeda's strategic expansions and acquisitions.
Conversely, Exelixis, a dynamic biotech firm, has experienced a remarkable revenue increase of over 7,000% during the same period, reflecting its successful drug development and market penetration strategies. Starting from a modest $25 million in 2014, Exelixis reached nearly $1.8 billion by 2023.
While Takeda's revenue growth is steady, Exelixis's exponential rise highlights the potential of innovative biotech firms in the pharmaceutical sector. Notably, data for 2024 is incomplete, leaving room for speculation on future trends.
Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Revenue Insights: Takeda Pharmaceutical Company Limited and MiMedx Group, Inc. Performance Compared
Annual Revenue Comparison: Exelixis, Inc. vs Pharming Group N.V.
Who Generates More Revenue? Exelixis, Inc. or Cytokinetics, Incorporated
Exelixis, Inc. and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Exelixis, Inc. vs Taro Pharmaceutical Industries Ltd.